Thiamin (vitamin B1) biosynthesis and regulation: A rich source of antimicrobial drug targets?

International Journal of Biological Sciences

Volumn 7, Issue 1, 2011, Pages 41-52

  Du, Qinglin ^a   Wang, Honghai ^b   Xie, Jianping ^a,b  

^a SOUTHWEST UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Drug targets; Mycobacterium tuberculosis; Riboswitch; Thiamin biosynthesis

Indexed keywords

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 79952467900     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.41     Document Type: Review

References (90)

1. Spry C, Kirk K., and Saliba K.J. Coenzyme A biosynthesis: an antimicrobial drug target. Fems Microbiology Reviews. 2008; 32: 56-106.
2. Mdluli K and Spigelman M. Novel targets for tuberculosis drug discovery. Current Opinion in Pharmacology. 2006; 6: 459-67.
3. Magni G, Di Stefano M, Orsomando G., et al. NAD (P) biosynthesis enzymes as potential targets for selective drug design. Current Medicinal Chemistry. 2009; 16: 1372-90.
4. Settembre E, Begley T.P., and Ealick S.E. Structural biology of enzymes of the thi ami n bi osynthesi s pathway. Curr Opi n Struct Biol. 2003; 13: 739-47.
5. Begley T.P, Downs D.M., Ealick S.E., et al. Thiamin biosynthesis in prokaryotes. Arch Microbiol. 1999; 171: 293-300.
6. Pohl M, Sprenger G.A., and Muller M. A new perspective on thiamine catalysis. Curr Opin Biotechnol. 2004; 15: 335-42.
7. Muller I.B, Hyde J.E., and Wrenger C. Vitamin B metabolism in Plasmodium falciparum as a source of drug targets. Trends in Parasitology. 2010; 26: 35-43.
8. McCourt J.A, Pang S.S., King-Scott J., et al. Herbicide-binding sites revealed in the structure of plant acetohydroxyacid synthase. Proc Natl Acad Sci U S A. 2006; 103: 569-73.
9. Kalme S, Pham C.N., Gedi V., et al. Inhibitors of Bacillus anthracis acetohydroxyacid synthase. Enzyme and Microbial Technology. 2008; 43: 270-275.
10. Choi K.J, Yu Y.G., Hahn H.G., et al. Characterization of acetohydroxyacid synthase from Mycobacterium tuberculosis and the identification of its new inhibitor from the screening of a chemical library. FEBS Lett. 2005; 579: 4903-10.
11. Zilles J.L, Croal L.R., and Downs D.M. Action of the thiamine antagonist bacimethrin on thiamine biosynthesis. J Bacteriol. 2000; 182: 5606-10.
12. Reddick J.J, Saha S., Lee J., et al. The mechanism of action of bacimethrin, a naturally occurring thiamin antimetabolite. Bioorg Med Chem Lett. 2001; 11: 2245-8.
13. Hirsch A. K. H and Diederich F. The non-mevalonate pathway to isoprenoid biosynthesis: A potenti al source of new drug targets. Chimia. 2008; 62: 226-230.
14. Mann S, Melero CP, Hawksley D., et al. Inhibition of thiamin diphosphate dependent enzymes by 3-deazathiamin diphosphate. Organic & Biomolecular Chemistry. 2004; 2: 1732-41.
15. Nemeria N.S, Korotchkina L.G., Chakraborty S., et al. Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex. Bioorg Chem. 2006; 34: 362-79.
16. Xiong Y, Li Y., He H., et al. Theoretical calculation of the binding free energies for pyruvate dehydrogenase E1 binding with ligands. Bioorg Med Chem Lett. 2007; 17: 5186-90.
17. Nemeria N, Yan Y., Zhang Z., et al. Inhibition of the Escherichia coli pyruvate dehydrogenase complex E1 subunit and its tyrosine 177 variants by thiamin 2-thiazolone and thiamin 2-thiothiazolone diphosphates. Evidence for reversible tight-binding inhibition. J Biol Chem. 2001; 276: 45969-78.
18. Rais B, Comin B., Puigjaner J., et al. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle. FEBS Lett. 1999; 456: 113-8.
19. Le Huerou Y, Gunawardana I., Thomas A.A., et al. Prodrug thiamine analogs as inhibitors of the enzyme transketolase. Bioorg Med Chem Lett. 2008; 18: 505-8.
20. Agyei-Owusu K and Leeper F.J. Thiamin diphosphate in biological chemistry: analogues of thiamin diphosphate in studies of enzymes and riboswitches. FEBS J. 2009; 276: 2905-16.
21. Bange F.C, Brown A.M., and Jacobs W. R. Jr. Leuci ne auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect Immun. 1996; 64: 1794-9.
22. Guleria I, Teitelbaum R., McAdam R.A., et al. Auxotrophic vaccines for tuberculosis. Nat Med. 1996; 2: 334-7.
23. Atkins T, Prior R.G., Mack K., et al. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect Immun. 2002; 70: 5290-4.
24. Zohar Y, Einav M., Chipman D.M., et al. Acetohydroxyacid synthase from Mycobacterium avium and its inhibition by sulfonylureas and imidazolinones. Biochim Biophys Acta. 2003; 1649: 97-105.
25. Sohn H, Lee K.S., Ko Y.K., et al. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Int J Antimicrob Agents. 2008; 31: 567-71.
26. Gedi V, Jayaraman K., Kalme S., et al. Evaluation of substituted triazol-1-yl-pyrimidines as inhibitors of Bacillus anthracis acetohydroxyacid synthase. Biochim Biophys Acta. 2010; 1804: 1369-75.
27. Joshi S. Identification of potential P. falciparum transketolase inhibitors: pharmacophore design, in silico screening and docking studies. Journal of Biophysical Chemistry. 2010; 01: 96-104.
28. Lawhorn B.G, Mehl R.A., and Begley T.P. Biosynthesis of the thiamin pyrimidine: the reconstitution of a remarkable rearrangement reaction. Organic & Biomolecular Chemistry. 2004; 2: 2538-46.
29. Vander Horn P.B, Backstrom A.D., Stewart V., et al. Structural genes for thiamine biosynthetic enzymes (thiCEFGH) in Escherichia coli K-12. J Bacteriol. 1993; 175: 982-92.
30. Sprenger G.A, Schorken U., Wiegert T., et al. Identification of a thiamin-dependent synthase in Escherichia coli required for the formation of the 1-deoxy-D-xylulose 5-phosphate precursor to isoprenoids, thiamin, and pyridoxol. Proc Natl Acad Sci U S A. 1997; 94: 12857-62.
31. Taylor S.V, Kelleher N.L., Kinsland C., et al. Thiamin biosynthesis in Escherichia coli. Identification of this thiocarboxylate as the immediate sulfur donor in the thiazole formation. J Biol Chem. 1998; 273: 16555-60.
32. Xi J, Ge Y., Kinsland C., et al. Biosynthesis of the thiazole moiety of thiamin in Escherichia coli: identification of an acyldisulfide- linked protein--protein conjugate that is functionally analogous to the ubiquitin/E1 complex. Proc Natl Acad Sci U S A. 2001; 98: 8513-8.
33. Leonardi R, Fairhurst S.A., Kriek M., et al. Thiamine biosynthesis in Escherichia coli: isolation and initial characterisation of the ThiGH complex. FEBS Lett. 2003; 539: 95-9.
34. Martinez-Gomez N.C, Robers M., and Downs D.M. Mutational analysis of ThiH, a member of the radical S-adenosylmethionine (AdoMet) protein superfamily. Journal of Biological Chemistry. 2004; 279: 40505-40510.
35. Kriek M, Martins F., Leonardi R., et al. Thiazole synthase from Escherichia coli: an investigation of the substrates and purified proteins required for activity in vitro. J Biol Chem. 2007; 282: 17413-23.
36. Settembre E.C, Dorrestein P.C., Park J.H., et al. Structural and mechanistic studies on ThiO, a glycine oxidase essential for thiamin biosynthesis in Bacillus subtilis. Biochemistry. 2003; 42: 2971-81.
37. Jurgenson C.T, Begley T.P., and Ealick S.E. The structural and biochemical foundations of thiamin biosynthesis. Annu Rev Biochem. 2009; 78: 569-603.
38. Melnick J, Lis E., Park J.H., et al. Identification of the two missing bacterial genes involved in thiamine salvage: thiamine pyrophosphokinase and thiamine kinase. J Bacteriol. 2004; 186: 3660-2.
39. Webb E, Claas K., and Downs D. thiBPQ encodes an ABC transporter required for transport of thiamine and thiamine pyrophosphate in Salmonella typhimurium. J Biol Chem. 1998; 273: 8946-50.
40. Bellion E and Lash T.D. Transport of 2-methyl-4-amino-5-hydroxymethylpyrimidine by Salmonella typhimurium. Biochim Biophys Acta. 1983; 735: 337-40.
41. Bellion E, Lash T.D., and McKellar B.R. Transport of thiamine and 4-methyl-5-hydroxyethylthiazole by Salmonella typhimurium. Biochim Biophys Acta. 1983; 735: 331-6.
42. Rodionov D.A, Vitreschak A.G., Mironov A.A., et al. Comparative genomics of thiamin biosynthesis in procaryotes. New genes and regulatory mechanisms. J Biol Chem. 2002; 277: 48949-59.
43. Devedjiev Y, Surendranath Y., Derewenda U., et al. The structure and ligand binding properties of the B. subtilis YkoF gene product, a member of a novel family of thiamin/HMP-binding proteins. J Mol Biol. 2004; 343: 395-406.
44. Gelfand M.S and Rodionov D.A. Comparative genomics and functional annotation of bacterial transporters. Physics of Life Reviews. 2008; 5: 22-49.
45. Jenkins A.H, Schyns G., Potot S., et al. A new thiamin salvage pathway. Nat Chem Biol. 2007; 3: 492-7.
46. Hirai K, Aoyama H., Irikura T., et al. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob Agents Chemother. 1986; 29: 535-8.
47. Danilchanka O, Pavlenok M., and Niederweis M. Role of porins for uptake of antibiotics by Mycobacterium smegmatis. Antimicrob Agents Chemother. 2008; 52: 3127-34.
48. Schauer K, Stolz J., Scherer S., et al. Both thiamine uptake and biosynthesis of thiamine precursors are required for intracellular replication of Listeria monocytogenes. J Bacteriol. 2009; 191: 2218-27.
49. Schwender J, Seemann M., Lichtenthaler H.K., et al. Biosynthesis of isoprenoids (carotenoids, sterols, prenyl side-chains of chlorophylls and plastoquinone) via a novel pyruvate/ glyceraldehyde 3-phosphate non-mevalonate pathway in the green alga Scenedesmus obliquus. Biochem J. 1996; 316 (Pt 1): 73-80.
50. Hill R.E, Himmeldirk K., Kennedy I.A., et al. The biogenetic anatomy of vitamin B6. A 13C NMR investigation of the biosynthesis of pyridoxol in Escherichia coli. J Biol Chem. 1996; 271: 30426-35.
51. Lange B.M, Rujan T., Martin W., et al. Isoprenoid biosynthesis: the evolution of two ancient and distinct pathways across genomes. Proc Natl Acad Sci U S A. 2000; 97: 13172-7.
52. Xiang S, Usunow G., Lange G., et al. Crystal structure of 1-deoxy-D-xylulose 5-phosphate synthase, a crucial enzyme for isoprenoids biosynthesis. J Biol Chem. 2007; 282: 2676-82.
53. Altincicek B, Hintz M., Sanderbrand S., et al. Tools for discovery of inhibitors of the 1-deoxy-D-xylulose 5-phosphate (DXP) synthase and DXP reductoisomerase: an approach with enzymes from the pathogenic bacterium Pseudomonas aeruginosa. FEMS Microbiol Lett. 2000; 190: 329-33.
54. Mueller C, Schwender J., Zeidler J., et al. Properties and inhibition of the first two enzymes of the non-mevalonate pathway of isoprenoid biosynthesis. Biochem Soc Trans. 2000; 28: 792-3.
55. Zeidler J, Schwender J., Mueller C., et al. The non-mevalonate isoprenoid biosynthesis of plants as a test system for drugs against malaria and pathogenic bacteria. Biochem Soc Trans. 2000; 28: 796-8.
56. Rodriguez-Concepcion M. The MEP pathway: a new target for the development of herbicides, antibiotics and antimalarial drugs. Curr Pharm Des. 2004; 10: 2391-400.
57. Mao J, Eoh H., He R., et al. Structure-activity relationships of compounds targeting mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase. Bioorg Med Chem Lett. 2008; 18: 5320-3.
58. Chiu H.J, Reddick J.J., Begley T.P., et al. Crystal structure of thiamin phosphate synthase from Bacillus subtilis at 1.25 A resolution. Biochemistry. 1999; 38: 6460-70.
59. Morett E, Saab-Rincon G., Olvera L., et al. Sensitive genome- wide screen for low secondary enzymatic activities: the YjbQ family shows thiamin phosphate synthase activity. J Mol Biol. 2008; 376: 839-53.
60. Reddick J.J, Nicewonger R., and Begley T.P. Mechanistic studies on thiamin phosphate synthase: evidence for a dissociative mechanism. Biochemistry. 2001; 40: 10095-102.
61. Park J.H, Dorrestein P.C., Zhai H., et al. Biosynthesis of the thiazole moiety of thiamin pyrophosphate (vitamin B1). Biochemistry. 2003; 42: 12430-8.
62. Sassetti C.M, Boyd D.H., and Rubin E.J. Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol. 2003; 48: 77-84.
63. Mandal M and Breaker R.R. Gene regulation by riboswitches. Nat Rev Mol Cell Biol. 2004; 5: 451-63.
64. Nudler E and Mironov A.S. The riboswitch control of bacterial metabolism. Trends Biochem Sci. 2004; 29: 11-7.
65. Soukup J. K and Soukup G. A. Ri boswitches exert geneti c control through metabolite-induced conformational change. Curr Opin Struct Biol. 2004; 14: 344-9.
66. Coppins R.L, Hall K.B., and Groisman E.A. The intricate world of riboswitches. Curr Opin Microbiol. 2007; 10: 176-81.
67. Loh E, Dussurget O., Gripenland J., et al. A trans-acting riboswitch controls expression of the virulence regulator PrfA in Listeria monocytogenes. Cell. 2009; 139: 770-9.
68. Breaker R.R. Complex riboswitches. Science. 2008; 319: 1795-7.
69. Roth A and Breaker R.R. The structural and functional diversity of metabolite-binding riboswitches. Annu Rev Biochem. 2009; 78: 305-34.
70. Kubodera T, Watanabe M., Yoshiuchi K., et al. Thiamine- regulated gene expression of Aspergillus oryzae thiA requires splicing of the intron containing a riboswitch-like domain in the 5'-UTR. FEBS Lett. 2003; 555: 516-20.
71. Miranda-Rios J, Navarro M., and Soberon M. A conserved RNA structure (thi box) is involved in regulation of thiamin biosynthetic gene expression in bacteria. Proc Natl Acad Sci U S A. 2001; 98: 9736-41.
72. Sudarsan N, Barrick J.E., and Breaker R.R. Metabolite-binding RNA domains are present in the genes of eukaryotes. RNA. 2003; 9: 644-7.
73. Bettendorff L. At the crossroad of thiamine degradation and biosynthesis. Nat Chem Biol. 2007; 3: 454-5.
74. Croft M.T, Moulin M., Webb M.E., et al. Thiamine biosynthesis in algae is regulated by riboswitches. Proc Natl Acad Sci U S A. 2007; 104: 20770-5.
75. Kazanov M.D, Vitreschak A.G., and Gelfand MS. Abundance M.S and functional diversity of riboswitches in microbial communities. BMC Genomics. 2007; 8: 347.
76. Serganov A, Polonskaia A., Phan A.T., et al. Structural basis for gene regulation by a thiamine pyrophosphate-sensing riboswitch. Nature. 2006; 441: 1167-71.
77. Thore S, Leibundgut M., and Ban N. Structure of the eukaryotic thiamine pyrophosphate riboswitch with its regulatory ligand. Science. 2006; 312: 1208-11.
78. Blount K.F and Breaker R.R. Riboswitches as antibacterial drug targets. Nat Biotechnol. 2006; 24: 1558-64.
79. Nudler E. Flipping riboswitches. Cell. 2006; 126: 19-22.
80. Gusarov I and Nudler E. The mechanism of intrinsic transcription termination. Mol Cell. 1999; 3: 495-504.
81. Yarnell W.S and Roberts J.W. Mechanism of intrinsic transcription termination and antitermination. Science. 1999; 284: 611-5.
82. Thomas J.R and Hergenrother P.J. Targeting RNA with small molecules. Chem Rev. 2008; 108: 1171-224.
83. Monaghan R.L and Barrett J.F. Antibacterial drug discovery-- then, now and the genomics future. Biochem Pharmacol. 2006; 71: 901-9.
84. Sudarsan N, Cohen-Chalamish S., Nakamura S., et al. Thiamine pyrophosphate riboswitches are targets for the antimicrobial compound pyrithiamine. Chem Biol. 2005; 12: 1325-35.
85. Mulhbacher J, Brouillette E., Allard M., et al. Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. PLoS Pathog. 2010; 6: e1000865.
86. Kim J.N, Blount K.F., Puskarz I., et al. Design and antimicrobial action of purine analogues that bind Guanine riboswitches. ACS Chem Biol. 2009; 4: 915-27.
87. Lea C.R and Piccirilli J.A. 'Turning on' riboswitches to their antibacterial potential. Nat Chem Biol. 2007; 3: 16-7.
88. Blouin S, Mulhbacher J., Penedo J.C., et al. Riboswitches: ancient and promising genetic regulators. Chembiochem. 2009; 10: 400-16.
89. Breaker R.R. Riboswitches: from ancient gene-control systems to modern drug targets. Future Microbiol. 2009; 4: 771-3.
90. Tian J, Bryk R., Itoh M., et al. Variant tricarboxylic acid cycle in Mycobacterium tuberculosis: identification of alpha- ketoglutarate decarboxylase. Proc Natl Acad Sci U S A. 2005; 102: 10670-5.